Advanced SearchSearch Tips
Expression of ER, PR, C-erbB-2 and Ki-67 in Endometrial Carcinoma and their Relationships with the Clinicopathological Features
facebook(new window)  Pirnt(new window) E-mail(new window) Excel Download
 Title & Authors
Expression of ER, PR, C-erbB-2 and Ki-67 in Endometrial Carcinoma and their Relationships with the Clinicopathological Features
Yu, Cui-Ge; Jiang, Xiang-Yang; Li, Bin; Gan, Lu; Huang, Jian-Feng;
  PDF(new window)
Background: To analyze the expression of estrogen receptors (ER), progesterone receptors (PR), C-erbB-2 and Ki-67 in endometrial carcinoma (EC) and their relationships with the clinicopathological features. Materials and Methods: Sixty-seven EC samples, 53 normal endometrial samples and 53 atypical hyperplasia endometrial samples were all selected in Shaanxi Provincial People`s Hospital from Jun., 2012 to Jun., 2014. The expression of ER, PR, C-erbB-2 and Ki-67 in EC tissue, normal endometrial tissue and atypical hyperplasia endometrial tissue was respectively detected using immunohistochemical SP method. The relationships between the expression of ER, PR, C-erbB-2 and Ki-67 and the patients` clinicopathological features as well as their correlations in EC tissue were also analyzed. Results: The positive expression rates of ER and PR in EC tissue were 44.8% and 41.8%, respectively, dramatically lower than in atypical hyperplasia endometrial tissue and normal endometrial tissue (P<0.01). The positive expression rates of C-erbB-2 and Ki-67 in EC tissue were 80.6% and 64.2%, respectively, significantly higher than in atypical hyperplasia endometrial tissue and normal endometrial tissue (P<0.01). In EC tissue, the expression of ER and PR was closely associated with the differentiated degrees and depth of myometrial invasion (P<0.05), while that of C-erbB-2 and Ki-67 with the clinical staging, differentiated degrees, depth of myometrial invasion and presence or absence of lymph node metastasis (P<0.05). Spearman correlation analysis further displayed that the expression of ER was positively correlated with PR (r
Estrogen receptors;progesterone receptors;C-erbB-2;Ki-67;endometrial carcinoma;
 Cited by
Binder PS, Mutch DG (2014). Update on prognostic markers for endometrial cancer. Womens Health (Lond Engl), 10, 277-88. crossref(new window)

Faria SC, Sagebiel T, Balachandran A, et al (2015). Imaging in endometrial carcinoma. Indian J Radiol Imaging, 25, 137-47. crossref(new window)

Gurda GT, Baras AS, Kurman RJ (2014). Ki-67 index as an ancillary tool in the differential diagnosis of proliferative endometrial lesions with secretory change. Int J Gynecol Pathol, 33, 114-9. crossref(new window)

Hong B, Le Gallo M, Bell DW (2015). The mutational landscape of endometrial cancer. Curr Opin Genet Dev, 30, 25-31. crossref(new window)

Ioachin E (2005). Immunohistochemical tumour markers in endometrial carcinoma. Eur J Gynaecol Oncol, 26, 363-71.

Ito K, Sasano H, Yabuki N, et al (1997). Immunohistochemical study of Ki-67 and DNA topoisomerase II in human endometrium. Mod Pathol, 10, 289-94.

Kajo K, Vallova M, Biro C, et al (2015). Molecular pathology of endometrial carcinoma - a review. Cesk Patol, 51, 65-73.

Kuramoto H, Hata H, Kato Y, et al (1989). Mechanism of action of endocrine therapy of endometrial carcinoma. Gan To Kagaku Ryoho, 16, 1851-7.

Morrison C, Zanagnolo V, Ramirez N, et al (2006). HER-2 is an independent prognostic factor in endometrial cancer: association with outcome in a large cohort of surgically staged patients. J Clin Oncol, 24, 2376-85. crossref(new window)

Seki A, Nakamura K, Kodama J, et al (1998). A close correlation between c-erbB-2 gene amplification and local progression in endometrial adenocarcinoma. Eur J Gynaecol Oncol, 19, 90-2.

Sharifah NA, Lee BR, Clarence-Ko CH, et al (2008). C-erbB-2 onco-protein expression in breast cancer: relationship to tumour characteristics and short-term survival in Universiti Kebansaan Malaysia Medical Centre. Asian Pac J Cancer Prev, 9, 663-70.

Srijaipracharoen S, Tangjitgamol S, Tanvanich S, et al (2010). Expression of ER, PR, and Her-2/neu in endometrial cancer: a clinicopathological study. Asian Pac J Cancer Prev, 11, 215-20.

Takahashi R, Mabuchi S, Kawano M, et al (2015). Prognostic significance of systemic neutrophil and leukocyte alterations in surgically treated endometrial cancer patients: a monoinstitutional study. Gynecol Oncol, 137, 112-8.

Thompson SK, Sullivan TR, Davies R, et al (2011). Her-2/neu gene amplification in esophageal adenocarcinoma and its influence on survival. Ann Surg Oncol, 18, 2010-17. crossref(new window)

Uharcek P (2008). Prognostic factors in endometrial carcinoma. J Obstet Gynaecol Res, 34, 776-83. crossref(new window)

Zhao FJ, Zhang SL, Ma L, et al (2009). Inhibitory effects of c-erbB-2 antisense oligonucleotide transfection on uterine endometrial cancer Ishikawa cell lines. Eur J Gynaecol Oncol, 30, 54-9.